Registry of Lobbyists
| Organization: | Novo Nordisk Canada Inc. |
| Associated registration: | 954988-360616-17 |
| Communication date: | 2023-11-14 |
| Posted date: | 2023-12-15 |
| Designated Public Office Holders who participated in the communication: |
Michael Collins,
Vice-President
Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada (PHAC) Marie-Pier Fontaine, Senior Policy Advisor Deputy Minister's Office, Health Canada (HC) Nancy Hamzawi, Executive Vice President Public Health Agency of Canada (PHAC) Stephen Lucas, Deputy Minister Health Canada (HC) Celia Lourenco, Acting Associate Assistant Deputy Minister Health Products and Food Branch, Health Canada (HC) |
| Subject Matter of the communication: | Health |
| Responsible Officer who filed this communication report: | Vince Lamanna |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |